Sort by
Medicine and Dentistry
Breast Cancer
100%
Overall Survival
57%
Metastatic Breast Cancer
47%
Triple Negative Breast Cancer
43%
Progression Free Survival
39%
Neoplasm
36%
Patient
33%
Next Generation Sequencing
32%
Lymphocyte
30%
Gamma Urogastrone
24%
Tumor Infiltrating Lymphocyte
23%
Epidermal Growth Factor Receptor
23%
Inpatient
22%
Adjuvant Chemotherapy
22%
Onset Age
21%
Fluorodeoxyglucose F 18
21%
Non Small Cell Lung Cancer
19%
Disease Free Survival
19%
Hazard Ratio
18%
Lung Cancer
18%
Bone Metastasis
16%
Positron Emission Tomography-Computed Tomography
16%
Palbociclib
16%
Brain Metastasis
16%
Lung Adenocarcinoma
16%
Androgen Receptor
15%
Recurrence Free Survival
15%
Clinical Feature
14%
Small Cell Lung Cancer
14%
Trastuzumab
14%
Malignant Neoplasm
14%
Survival
14%
Neutrophil
14%
Neoadjuvant Chemotherapy
14%
Lymphocyte
13%
Neutrophil
13%
Immunohistochemistry
13%
Gene Expression
13%
Receptor Subtype
13%
Epidermal Growth Factor Receptor 2
12%
Clear Cell Renal Cell Carcinoma
11%
Hormone Therapy
11%
Breast
11%
Anthracycline
11%
Prognostic Factor
11%
Hormone Receptor
11%
Abdominal Cancer
10%
Programmed Death 1 Ligand 1
10%
Lymphovascular Invasion
10%
Glucose Transporter 1
10%
Pharmacology, Toxicology and Pharmaceutical Science
Metastatic Breast Cancer
48%
Overall Survival
45%
Cisplatin
41%
Chemotherapy
36%
Progression Free Survival
30%
Breast Cancer
28%
Triple Negative Breast Cancer
28%
Palbociclib
21%
Capecitabine
20%
Doxorubicin
20%
Gamma Urogastrone
18%
Non Small Cell Lung Cancer
17%
Hormone Receptor
17%
Anthracycline
16%
Taxane
16%
Neoplasm
15%
Overall Survival
13%
Gemcitabine
12%
Cardiotoxicity
12%
Paclitaxel
12%
Monotherapy
12%
Neutropenia
11%
Recurrent Disease
11%
Immune Checkpoint Inhibitor
11%
Epidermal Growth Factor Receptor
11%
Epithelium Tumor
10%
Gemcitabine
10%
Fluorodeoxyglucose F 18
10%
Meningoencephalitis
10%
Intraductal Carcinoma
10%
Small Cell Lung Cancer
10%
Carcinoembryonic Antigen
10%
Epidermal Growth Factor Receptor Kinase Inhibitor
10%
Bone Metastasis
10%
Metastatic Colorectal Cancer
10%
Listeria monocytogenes
10%
Retrospective Study
10%
Glucose Transporter 1
10%
Antibiotics
10%
Transforming Growth Factor Beta
10%
Atezolizumab
10%
Phase II Trials
10%
Neoplasm
9%
Diseases
8%
microRNA
8%
Letrozole
8%
Carcinoembryonic Antigen
7%
Platinum
6%
Trastuzumab
6%
Toxicity
6%
Biochemistry, Genetics and Molecular Biology
Overall Survival
23%
Next Generation Sequencing
20%
Epidermal Growth Factor Receptor
17%
SOX2
16%
Colon
13%
Homologous Recombination
12%
Germline
12%
Germ Cell
12%
Fusion Gene
10%
KIF5B
10%
Tumor Gene
10%
KRAS
10%
Antibiotic Sensitivity
10%
Tumor Gene
10%
Capecitabine
10%
Disease Free Survival
10%
Whole Genome Sequencing
10%
Gene Mutation
9%
Immunostaining
9%
Carcinogenesis
8%
Cancer Cell
8%
PD-L1
7%
Gene Expression Data
7%
Progression Free Survival
7%
Circulating Tumor DNA
6%
Genetic Screening
6%
BRCA1
6%
Angiogenesis
6%
Phase II Trials
6%
Phenol Red
6%
Anthracycline
5%
Neutrophil-To-Lymphocyte Ratio
5%
Case Report
5%
Age
5%
Immune Checkpoints
5%
Mutated Genes
5%
Homologous Recombination
5%
Saponin
5%
Plasmid
5%
Phylogeny
5%
Doxorubicin
5%
Androgen Receptor
5%
Saponin
5%
Escherichia coli
5%
Escherichia coli
5%
NLRP2
5%
Angiogenesis
5%
Cancer Staging
5%
Tumor-Infiltrating Lymphocytes
5%
Carvedilol
5%
